Clarifies Bundled Sales Definition, Provides Strategies for Reducing RevenueLeakage
Visit Booth # 7, Sept. 15-17, 2014 and the Alliance Life Sciences Blog
SOMERSET, N.J. / LONDON – September 15, 2014 – Alliance Life Sciences, a global innovator that solves complex commercial problems, announces that it will sponsor the IIR 19th Annual Summit on Medicaid Drug Rebate Program (MDRP), Sept. 15-17, 2014, Chicago Marriott Downtown Magnificent Mile, Chicago, Booth # 7. Ryan McKinney, director of Government Pricing, will present “Clarifications to the Bundled Sales Definition,” and Lois Byra, vice president, Contracting and Pricing Solutions, will participate in a panel entitled, “Reduce Revenue Leakage Through Medicaid Rebates Operation Excellence & Performance Analytics.”
“The MDRP Summit is one of the biggest industry events for examining government pricing, rebates, and contracting regulations,” says Byra. “Alliance LIfe Sciences helps companies solve business problems and streamline their processes for reassessing strategic and tactical focus and leveraging opportunities.”
McKinney will address issues related to one of the bigger implications of the pending Average Manufacturer Price (AMP) Rule, which is the re-definition of what constitutes a bundled sale. For more information, a post is available on the Alliance LIfe Sciences blog.
The panel Byra is participating in will help attendees better understand where they stand in rebate processing maturity, and outline how to ensure that only legitimate claim data is paid out to prevent substantial overbilling and better predict accurate monthly payments.
Byra adds, “As the industry continues to evolve and regulations change, Alliance LIfe Sciences is dedicated to helping customers unlock business value with unique solutions to their complex commercial problems.”